TrialNature medicine2022
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.
A Italiano et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
182 papers cite itlatest 60 shown
this paperpooled ittrialcites it